Anyone who wants to submit to The Osong Public Health and Research Perspectives should follow the below instructions. If otherwise not mentioned, it follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org), which were established by the International Committee of Medical Journal Editors(ICMJE).
Research and publication ethics
For policies on research and publication ethics not stated in these instructions, please consult “Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/publishing_ethics.html)” or “Guidelines on Good Publication (http://www.publicationethics.org.uk/guidelines)”.
Statement of human and animal rights: Clinical research studies must state that the work was done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration of 1975 (revised in 2008). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects must not be identifiable. Patients’ names, initials, hospital number, date of birth,or other protected healthcare information must not be disclosed. Animal research studies must state that the work was performed according to National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals must be observed.Statement of informed consent: Human studies must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the beginning of the Materials and Methods section. Any systematic data gathering effort from patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author(s).
Clinical Trials Registry
We strongly recommend, as a condition of consideration for publication, registration in a public or national clinical trials registry. Trials must be registered at or before the onset of patient enrollment. This policy applies to any clinical trial where enrollment commenced after January 1, 2011. For trials preceding this enrollment date, we request registration by January 1, 2012, before the trial will be considered for publication. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as studies on pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt. Examples of clinical trial registration sites are the Clinical Research Information Service maintained by Korea Centers for Diseases Control and Prevention, Republic of Korea (http:// ncrc.cdc.go.kr/cris) or registry sponsored by the United States National Library of Medicine (www.clinicaltrials.gov).
Authorship credit must be based on:
1) substantial contributions to the concept and design, or acquisition of data, or analysis and interpretation of data;
2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. All authors must meet the above three conditions. If the number of authors exceeds six, the specific role(s) of authors should be described at the end of the main text.
All published manuscripts become the permanent property of Korea Centers for Disease Control and Prevention . All authors should sign a 'Copyright Transfer and Conflict of Interest Disclosure' form and submit it with the manuscript. The form is available in the journal's homepage at http://www.kcdc-phrp.org.
This journal is a peer reviewed, open access (free submission and free access) journal where the Korea Centers for Disease Control and Prevention pays for the publishing costs incurred by the journal. Authors do not have to pay any Article Processing Charge or Open Access Publication Fee.User Rights
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by the following user license:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article. Author Rights
For open access publishing, this journal uses a copyright transfer agreement. Authors will need to transfer copyright to the Korea Centers for Disease Control and Prevention and grant Elsevier publishing and distribution rights. Authors will retain scholarly usage rights.
Review articles provide a concise review on subjects of importance to medical researchers. The word count of review articles should not exceed 5,000 words. Review articles are usually invited.Original articles are papers containing results of basic and clinical investigations, which are sufficiently well documented to be acceptable to critical readers. The word count of original articles should not exceed 3,000 words.
Brief reports deal with issues of importance to biomedical researchers. The maximum length of the manuscript should be 2,000 words including tables and figures.Correspondence is a comment from readers regarding a published article with a reply from the authors of the article.
Book reviews may be published. Please dispatch a book to the editorial office if you think the book is essential to public health personnel.Manuscript Preparation
All materials must be written in proper and clear English. The manuscript including tables and their footnotes, and figure legends, must be typed double-spaced on white A4 paper, with a margin of at least 2.5 cm on every side.Materials should be prepared with a letter quality printer using a ragged right margin and standard 12-point font. The manuscript should be in the following sequence: title page, abstract and keywords, introduction, materials and methods, results, discussion, acknowledgments, references, tables, and figure legends. All pages should be number consecutively starting from the title page.
Title page:This should contain the title of your manuscript, the full names of authors and institutional affiliation(s). If several authors and institutions are listed, the affiliation of each author should be clearly indicated. In a separate paragraph, the postal address for correspondence (institutional affiliation, city, zip-code and country), name of the corresponding author, highest degree obtained, telephone and fax numbers, and e-mail address, should be provided. Information concerning sources of financial support should be inserted as a footnote. A running title less than ten words should also be included. Abstract and Keywords
The Abstract should be less than 250 words, and describe the purpose, methods, results, and conclusion of the study in a structured format. Abbreviations, if needed, should be kept to an absolute minimum. Abstracts for case report may deviate from this format, but carry the same word count restrictions.Abstracts are not required for correspondence. Original articles and brief reports should provide structured abstracts with the following headings: objectives, methods, results and conclusion. Structured abstracts are not required for Reviews. Up to ten keywords should be listed at the bottom of the abstract for use in indexing. For the keyword selection, refer to the medical subject heading (MeSH) list, available from: http://www.nlm.nih.gov/mesh/Mbrowser.html.
Introduction: The Introduction should give a brief background of the topic, generally informing the reader of the relevant findings of others and referencing the most pertinent publications. Specific questions about the authors’ particular investigation and what was studied should also be described.Materials and Methods
We endorse the principles embodied in the Declaration of Helsinki and expect that all investigations involving human materials have been performed in accordance with these principles. For animal experiments, the “Guiding Principles in the Care and Use of Animals” approved by the American Physiological Society must be observed. Explanation of the experimental methods should be concise and sufficient for repetition by other qualified investigators. Procedures that have been published previously do not need to be described in detail. However, new or significant modifications of previously published procedures require full descriptions. The sources of special chemicals or preparations should be given along with their location (name of company, city, state, and country). Method of statistical analyses and criteria of significance level should be described. In Case Reports, case history or case description can replace the Materials and Methods section as well as the Results section.
Results:This section should be presented logically using text, table and illustrations. Excessive repetition of table or figure contents should be avoided. Discussion: The data should be interpreted concisely without repeating material already presented in the Results.Speculation is permitted, but it must be supported by the authors’ presented data and be well founded. Conflicts of interest
Any conflicts of interest related to the work must be disclosed.
Acknowledgments:All persons who have made substantial contribution, but who are not eligible as authors can be recognized in the Acknowledgments section. References
Citation of references in the text should be made by giving consecutive number in bracket (NLM style). They should be listed in the order of citation in the text with consecutive number in this separate section. It follows Patrias K. Citing medicine: the NLM style guide for authors, editors, and publishers [Internet]. 2nd ed. Wendling DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007 [updated 2009 Oct 21; cited 2011 Mar 8y]. Available from: http://www.nlm.nih.gov/citingmedicinehttp://www.nlm.nih.gov/citingmedicine. Papers in press may be listed among the references with the journal name and tentative year of publication.Unpublished data or personal communications can be listed only with the author’s written permission.
1. Hamelin M, Yim K, Kuhn KH, et al. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol 2005 Jul;79(4):8894 -903.
2. Berliz HD, Grosch W, Schieberlie P. Food Chemistry, 3rd ed. Burghaegn MM, translator, Berlin: Springer; 2004, 1970p.
Tables and Figures: Tables and figures should be submitted separately from the main manuscript, and figure legends should be typed on separate sheets.Tables should be simple and should not duplicate the information given in figures. Include a title for all tables and number them with Arabic numerals in the order of their citation. Type each table on a separate sheet and describe all abbreviations. Each column should have an appropriate heading, and if numerical measurements are given, the unit should be included in the column heading. The significance of results should be indicated by appropriate statistical analysis. Table footnotes should be indicated with superscript markings. All units of measurement and concentration should be designated.
Flow diagram and complex biochemical structures should be prepared professionally. Graphics should be used only when a relevant point needs illustration. Clear, glossy prints are acceptable instead of original drawings, provided that all parts of the figures are in focus. X-ray films or Polaroid photographs are not acceptable. Except for extremely complicated drawings, which show large amounts of data, all figures are published at one page or one column width. When the fi gures are reduced to the size of a single column or single page width, the smallest parts of the figure must be legible, otherwise the figures will be returned to the author for revision. Points of observations should be noted with different symbols rather than with different types of lines and their signifi cance can be directly shown in the body of the figure or in the legend.
Only those common symbols for which the printer has type should be used. If a figure contains a left- and right-hand ordinate, explanation of the left ordinate should read upwards and the right ordinate should read downwards.
All figure legends should be typed double spaced. Do not use a separate sheet for each legend. Figure legends should briefl y describe the data shown, explain any abbreviations or reference points in the photographs, and identify all units, mathematical expressions, abscissa, ordinates and symbols.Units: Système International (SI) units should be used throughout
Electronic manuscript submission
The manuscript file should be mailed to the editorial office. The preferred file type is Microsoft Word or RTF. Label the file with the name of the corresponding author, and the first three words of the title of the manuscript. Manuscript files should be submitted via http://www.evise.com/evise/faces/pages/navigation/NavController.jspx?JRNL_ACR=PHRP. Preferred file formats for the main text and tables are doc or rtf. The file format of figures should be ppt or tif at least 600 dpi resolution. If authors have difficulty in submitting the manuscripts, please contact the editorial office. Authors should download the Copyright Transfer Form in the website and submit it with manuscripts.
The Osong Public Health and Research Perspectives
Korea Centers for Disease Control and Prevention
187 Osongsaengmyeong 2-ro, Osong-eup
The Republic of Korea 353-191
Phone: +82-43-249-3030 (office), +82-10-2667-0397(cellular)
The Osong Public health and Research Perspectives review all received materials. Manuscripts are reviewed for English if the author is not a native English speaker. Manuscripts are sent to the three most relevant investigators for review of the contents. The editor selects peer reviewers via recommendations from Editorial Board members or from the specialist database owned by the Editorial Board. If deemed necessary, a review of statistics may be additionally requested. For review, names and their affi liations of the authors are blinded. Also, the identities of the reviewers will not be revealed. Acceptance of the manuscript is decided, based on the critiques and recommended decision of the reviewers. A reviewer’s decision can be “acceptance without revision”, “acceptance after minor revisions”, “review again after revisions”, and “rejection”. The reviewed manuscripts are returned back to the corresponding author with comments and recommended revisions. A final decision regarding acceptance or rejection for publication is forwarded to the corresponding author from the Editorial Office. The peer review process usually takes usually two to four weeks after manuscript submission.
Revision: Revisions are usually requested to take into account the criticisms and comments made by the reviewers. The revised manuscript should be re-submitted with the original illustrations. Failure to resubmit the revised manuscript within two months is regarded as a withdrawal. The corresponding author must indicate clearly what alterations have been made in response to the reviewers’ comments, point-by-point. Acceptable reasons should be given for noncompliance with any recommendation of the peer reviewers. Once accepted, manuscripts will be published within six months.
Alteration in Proof: The Osong Public health and Research Perspectives provides the corresponding author with proofs for their correction. Corrections should be kept to a minimum. The Editor retains the prerogative to question minor stylistic alterations and major alterations that might affect the scientifi c content of the paper. Faults found after publication are the responsibility of the authors. We urge our contributors to proofread their accepted manuscripts very carefully. The corresponding author may be contacted by the Editorial Offi ce, depending on the nature of the correction required in the proof. If the proof is not returned to the Editorial Offi ce within 48 hours, it may be necessary to reschedule publication of the paper in a subsequent issue.
There is no page charge or submission charge and print copies of manuscripts are freely available. Please contact the editorial office for the delivery of print copies.
Anyone who wants to submit to The Osong Public Health and Research Perspectives should follows the below instructions. If otherwise not mentioned, it follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org), which were established by the International Committee of Medical Journal Editors (ICMJE).Author’s check list before submission
1. Double-spaced on A4-size white paper with 12-point font, all pages numbered consecutively starting from the title page.
2. Manuscript sequence: title page, abstract and keywords, introduction, materials and methods, results, discussion, conflicts of interest, acknowledgments, references, tables and fi gure legends.
3. Title page with article title, authors’ full name(s) and affi liation, address for correspondence (including telephone, fax numbers and e-mail address), running title(less than 10 words), and footnotes, if any.
4. Abstract in a structured format within 250 words, and keywords according to MeSH.
5. All table and fi gure numbers found in the text.
6. References listed in the correct format. Check that all references listed in the references section are cited in the text and vice versa.
7. A covering letter stating the material is not published previously, and will not be submitted for publication elsewhere, and stating confl icts of interest of all listed authors, if any. Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.